CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0001 (-20.00%)
Dec 15, 2025, 11:58 AM EST
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $376.6 thousand as of December 15, 2025. Its market cap has decreased by -1.39% in one year.
Market Cap
376.60K
Enterprise Value
1.56M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has increased from 238.06K to 376.60K, an increase of 58.20%. That is a compound annual growth rate of 3.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 376.60K | 63.58% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | 28.16M | 71.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |